BMC Microbiology Микробиология
Targeted molecular and phenotypic characterization of ESBL-producing and carbapenem-resistant Klebsiella spp. isolated from urine and wound specimens in Togo
Аннотация
Klebsiella spp. are WHO critical-priority pathogens owing to their capacity to acquire resistance determinants, notably extended-spectrum β-lactamases (ESBLs) and carbapenemases. Combined phenotypic and molecular data on clinical Klebsiella isolates remain scarce in Togo. This study described phenotypic resistance and the targeted detection of 18 resistance genes in ESBL-producing and carbapenem-resistant Klebsiella spp. from clinical specimens. A multicentre cross-sectional study was conducted from October 2024 to June 2025 in 11 healthcare facilities. In total, 161 non-duplicate isolates labelled as ESBL-producing (n = 153) or carbapenem-resistant (n = 8) were recovered from urine (n = 124) and wound/pus (n = 37). Susceptibility to 35 antibiotics was determined (34 by disk diffusion, CLSI M100, 34th edition; colistin by broth microdilution). Eighteen resistance genes were sought by SYBR Green qPCR in 119 isolates. As isolates were selected on their resistance phenotype, proportions are not prevalence. K. pneumoniae subsp. pneumoniae accounted for 77.0% of isolates. Overall, 160 isolates (99.4%) were multidrug-resistant, one was extensively drug-resistant, and none was pan-drug-resistant. Resistance was highest for trimethoprim-sulfamethoxazole (85.1%), ceftriaxone (82.0%) and ceftazidime (73.3%), and lowest for ceftaroline (0.6%), nitrofurantoin (3.7%), imipenem (3.7%) and meropenem (4.3%); 18 isolates (11.2%) were resistant to at least one carbapenem. By qPCR, blaSHV (86.6%), bla CTX-M (54.6%) and bla TEM (37.0%) were the most frequent β-lactamase genes. bla NDM, bla KPC, bla OXA-48 and bla VIM were detected in 23 (19.3%), 13 (10.9%), 10 (8.4%) and 1/114 isolates, respectively, yet only 4 of 38 carbapenemase-gene-positive isolates were carbapenem-resistant, none to imipenem. mcr-1 was detected in 18 isolates (15.1%), one of which was colistin-resistant by broth microdilution. Resistance was very common in this selected collection, while carbapenemase and colistin-resistance genes were largely found in phenotypically susceptible isolates, requiring confirmation by sequencing and MIC determination. These in vitro results do not support treatment recommendations but support combined phenotypic and molecular surveillance and stewardship in Togo and West Africa. Clinical trial: Not applicable.